StocksMedium•6 November 2026•
1 min read
bioAffinity Technologies Reports $5.89 Q3 EPS Loss on $1.1 Million Revenue
Key Facts
1bioAffinity Technologies reported a GAAP EPS loss of $5.89.
2The company's revenue reached $1.1 million for the reported period.
bioAffinity Technologies reported a GAAP EPS loss of $5.89 for the third quarter of 2026. According to Seeking Alpha, the company's revenue reached $1.1 million for the period, marking a 21.4% decrease compared to the previous year.
Financial records show that bioAffinity Technologies held approximately $2.6 million in cash and cash equivalents as of September 30, 2026, down from $6.4 million on December 31, 2025. The stock BIAF closed at $2.6 on November 5, 2026, following a session range between $2.54 and $2.97.